BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33969792)

  • 1. Equal effect of vancomycin lock with or without heparin in treatment of central venous catheter related blood stream infections - an observational study in palliative home care.
    Ranch-Lundin M; Schedin A; Björkhem-Bergman L
    Infect Dis (Lond); 2021 Sep; 53(9):719-723. PubMed ID: 33969792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
    Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
    Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
    Wang Y; Sun X
    Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2016 Mar; 73(5):315-21. PubMed ID: 26896504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial.
    Lesens O; Forestier E; Botelho-Nevers E; Pavese P; David G; Nougarede B; Corbin V; Pereira B; Aumeran C; Sauvat L
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):223-232. PubMed ID: 37993679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
    Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
    Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: A prospective randomized study.
    Sofroniadou S; Revela I; Kouloubinis A; Makriniotou I; Zerbala S; Smirloglou D; Kalocheretis P; Drouzas A; Samonis G; Iatrou C
    Hemodial Int; 2017 Oct; 21(4):498-506. PubMed ID: 28078825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter lock solutions for reducing catheter-related bloodstream infections in paediatric patients: a network meta-analysis.
    Guo Q; Lv Z; Wang H; Song L; Liu Y; Chen H; Zhou C
    J Hosp Infect; 2021 Dec; 118():40-47. PubMed ID: 34560168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.
    Carratalà J; Niubó J; Fernández-Sevilla A; Juvé E; Castellsagué X; Berlanga J; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2200-4. PubMed ID: 10471564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between Vancomycin Lock and Taurolock Solution for the Prevention of Catheter- related Infections in Hemodialysis Patients, A Multicenter Study.
    Nassiri AA; Ahmadi Koomleh A; Sabaghian T; Delgosha M; Hakemi MS
    Iran J Kidney Dis; 2023 Jul; 17(4):215-221. PubMed ID: 37634248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M; Wright MJ; Akbani H; Laboi P; Bhandari S; Sandoe JA
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can vancomycin lock therapy extend the retention time of infected long-term catheters?
    Alonso B; Fernández-Cruz A; Díaz M; Sánchez-Carrillo C; Martín-Rabadán P; Bouza E; Muñoz P; Guembe M
    APMIS; 2020 Jun; 128(6):433-439. PubMed ID: 32012332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
    LaPlante KL; Mermel LA
    Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
    Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.